Works matching AU Oude Munnink, Thijs H.

Results: 11
    1

    TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1310, doi. 10.2967/jnumed.115.154401
    By:
    • den Hollander, Martha W.;
    • Bensch, Frederike;
    • Glaudemans, Andor W. J. M.;
    • Munnink, Thijs H. Oude;
    • Enting, Roelien H.;
    • den Dunnen, Wilfred F. A.;
    • Heesters, Mart A. A. M.;
    • Kruyt, Frank A. E.;
    • Lub-de Hooge, Marjolijn N.;
    • de Groot, Jan Cees;
    • Pearlberg, Joseph;
    • Gietema, Jourik A.;
    • de Vries, Elisabeth G. E.;
    • Walenkamp, Annemiek M. E.
    Publication type:
    Article
    2

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
    By:
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • van Es, Suzanne C.;
    • Nagengast, Wouter B.;
    • Munnink, Thijs H. Oude;
    • Lub-de Hooge, Marjolijn N.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • de Jong, Igle J.;
    • de Haas, Sanne;
    • Scherer, Stefan J.;
    • Sluiter, Wim J.;
    • Dierckx, Rudi A.;
    • Bongaerts, Alfons H. H.;
    • Gietema, Jourik A.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    3
    4
    5
    6

    <sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.

    Published in:
    Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
    By:
    • Nagengast, Wouter B.;
    • de Korte, Maarten A.;
    • Munnink, Thijs H. Oude;
    • Timmer-Bosscha, Hetty;
    • den Dunnen, Wifred F.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • Jensen, Michael R.;
    • Quadt, Cornelia;
    • Garcia-Echeverria, Carlos;
    • van Dongen, Guus A. M. S.;
    • Hooge, Marjolijn N. Lub-de;
    • Schröder, Carolien P.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    7
    8
    9

    Model-Informed Development of a Cost-Saving Dosing Regimen for Sacituzumab Govitecan.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 789, doi. 10.1007/s11523-024-01075-8
    By:
    • Moes, Dirk J. A. R.;
    • Hendrikx, Jeroen J. M. A.;
    • Guchelaar, Henk-Jan;
    • Mathijssen, Ron H. J.;
    • Bakker, J. L.;
    • Dezentjé, Vincent O.;
    • de Rouw, Nikki;
    • van Erp, Nielka P.;
    • Smit, Egbert F.;
    • van den Heuvel, Michel M.;
    • Munnink, Thijs H. Oude;
    • van Kats, Maartje;
    • Croes, Sander;
    • Kroep, Judith R.;
    • Zwaveling, Juliette;
    • ter Heine, Rob
    Publication type:
    Article
    10

    A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 3, p. 441, doi. 10.1007/s11523-023-00958-6
    By:
    • ter Heine, Rob;
    • van den Heuvel, Michel M.;
    • Piet, Berber;
    • Deenen, Maarten J.;
    • van der Wekken, Anthonie J.;
    • Hendriks, Lizza E. L.;
    • Croes, Sander;
    • van Geel, Robin M. J. M.;
    • Jansman, Frank G. A.;
    • Boshuizen, Rogier C.;
    • Franssen, Eric J. F.;
    • Smit, Arthur A. J.;
    • Dumoulin, Daphne W.;
    • Oude Munnink, Thijs H.;
    • Smit, Egbert F.;
    • Derijks, Hieronymus J.;
    • van der Leest, Cor H.;
    • Hendrikx, Jeroen J. M. A.;
    • Moes, Dirk J. A. R.;
    • de Rouw, Nikki
    Publication type:
    Article
    11